CHEMBIO DIAGNOSTICS INC(NASDAQ:CEMI) stock News

CEMI Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Life Science Outsourcing, Inc. - Mentions: APTV

Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

2 years ago - By: Benzinga - Mentions: BRKR FLDM EXAS HOLX ...

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year

2 years ago - By: Chembio Diagnostics, Inc.

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

2 years ago - By: Benzinga - Mentions: GOVX WRAP

Wrap Technologies And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

3 years ago - By: Chembio Diagnostics, Inc.

Chembio’s CEO Letter to Stockholders

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023

3 years ago - By: Chembio Diagnostics, Inc.

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023

3 years ago - By: Chembio Diagnostics, Inc.

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023

3 years ago - By: Chembio Diagnostics, Inc.

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Announces Letter to Stockholders Regarding Tender Offer

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

3 years ago - By: Kahn Swick & Foti, LLC

CHEMBIO DIAGNOSTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chembio Diagnostics, Inc. - CEMI

3 years ago - By: InvestorPlace - Mentions: MSGM QNRX RNAZ MRIN ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 years ago - By: Halper Sadeh LLC

CEMI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chembio Diagnostics, Inc. Is Fair to Shareholders

3 years ago - By: Seeking Alpha

Biosynex to buy Chembio Diagnostics (NASDAQ:CEMI) in $17.2M deal

3 years ago - By: Chembio Diagnostics, Inc.; Biosynex

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System

3 years ago - By: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Third Quarter 2022 Financial Results

3 years ago - By: Chembio Diagnostics, Inc.

CHEMBIO DIAGNOSTICS INC (CEMI) Stock News

CEMI Latest News, Press Relases and Analysis

Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Wrap Technologies And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Chembio’s CEO Letter to Stockholders

Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex

Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

Chembio Announces Letter to Stockholders Regarding Tender Offer

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

CHEMBIO DIAGNOSTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chembio Diagnostics, Inc. - CEMI

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

CEMI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chembio Diagnostics, Inc. Is Fair to Shareholders

Biosynex to buy Chembio Diagnostics (NASDAQ:CEMI) in $17.2M deal

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System

Chembio Diagnostics Reports Third Quarter 2022 Financial Results

Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022